Stay updated on Pembrolizumab After Weekly Paclitaxel Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab After Weekly Paclitaxel Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab After Weekly Paclitaxel Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing Revision: v3.6.3. This indicates a minor metadata update to the page rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-07-27T06:39:00.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page's revision stamp was updated from v3.6.2 to v3.6.3, signaling a minor update to the Study Details page without altering its content or conclusions.
    Difference
    0.1%
    Check dated 2026-07-05T14:37:35.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page footer shows a new revision tag, v3.6.2, and the previous revision tag, v3.6.0, was removed. This reflects a small platform update with no changes to the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-06-28T08:46:25.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    New help and navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note stating no longer looking for participants, plus a revision tag showing v3.6.0. The text label for a section was changed from 'Intervention / Treatment' to 'Intervention/Treatment'.
    Difference
    0.4%
    Check dated 2026-06-13T17:36:12.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.5.4 to v3.5.5, indicating a page version update. The change does not alter trial details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-06-06T14:00:55.000Z thumbnail image
  9. Check
    79 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page was updated to Completed with Results Posted, and new text describes the maintenance pembrolizumab approach after weekly paclitaxel in platinum-resistant ovarian cancer. It also notes the non-randomised phase II design, primary and secondary outcomes, and provides access to the protocol and statistical analysis plan.
    Difference
    3%
    Check dated 2026-05-23T10:31:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab After Weekly Paclitaxel Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Weekly Paclitaxel Clinical Trial page.